Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
Novo Nordisk’s rise to become an obesity powerhouse, only to find itself in a brutal battle for market share with its U.S. | Novo Nordisk CFO Karsten Munk Knudsen spoke to Fierce the morning the company unveiled its second-quarter earnings, reflecting on Novo’s “roller coaster” financial journey, the pressure of navigating its shifting fortunes and why he remains optimistic about CagriSema.
566 words~3 min read
